Unlike regular dialysis, which takes 3-4 hours, continuous dialysis runs 24 hours a day and is increasingly used in intensive care units for patients with acute kidney failure because it is far ...
SAN MATEO, Calif., Aug. 25, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
A recent meta-analysis concluded that continuous renal replacement therapy (CRRT) is not superior to intermittent renal replacement therapy (IRRT) in terms of hemodynamic control, renal recovery and ...
Serum lactate is a useful biomarker in risk stratification, according to investigators. Hyperlactatemia at initiation of continuous renal replacement therapy (CRRT) and reduced lactate clearance may ...
Neyra is the co-director of the Critical Care Nephrology program at UAB, co-director of the Clinical Core of the UAB-UCSD O'Brien Center for Acute Kidney Injury Research, and the associate director of ...
Hosted on MSN
Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad
CEO Vincent Angotti highlighted significant progress in the NEPHRO CRRT study, emphasizing the FDA-approved reduction in study size from 166 to 70 patients while maintaining 90% statistical power for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback